EMD-10462

Single-particle
3.4 Å
EMD-10462 Deposition: 07/11/2019
Map released: 26/08/2020
Last modified: 22/05/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-10462

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-6tcz summary report (pdf.gz) Map-6tcz FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Leishmania tarentolae proteasome 20S subunit complexed with LXE408

EMD-10462

Single-particle
3.4 Å
EMD-10462 Deposition: 07/11/2019
Map released: 26/08/2020
Last modified: 22/05/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Leishmania donovani
Sample: Leishmania tarentolae proteasome 20S subunit complex
Fitted models: 6tcz

Deposition Authors: Srinivas H
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases.
PUBMED: 32667203
DOI: doi:10.1021/acs.jmedchem.0c00499
ISSN: 0022-2623
ASTM: JMCMAR